Differences
This shows you the differences between two versions of the page.
| Both sides previous revision Previous revision Next revision | Previous revision | ||
|
en:start [2025/08/07 16:50] 127.0.0.1 external edit |
en:start [2025/08/24 15:38] (current) Gianluca Frustagli "Project GENEVAX": fixed link to logos. |
||
|---|---|---|---|
| Line 12: | Line 12: | ||
| The **[[https://www.iss.it|ISS]] - Core Facilities Technical-Scientific Service** is a centralized shared resource that provides access to instruments and technologies, as well as expert consultation, to scientific researchers. | The **[[https://www.iss.it|ISS]] - Core Facilities Technical-Scientific Service** is a centralized shared resource that provides access to instruments and technologies, as well as expert consultation, to scientific researchers. | ||
| - | {{map> :esagoni-eng.png?380|Core facilities}} | + | {{map> :esagoni-eng.png?300|Core facilities}} |
| /* "Logo" ad esagoni con mappa dei link. Le coordinate sono scalate sull'immagine ridimensionata, riscalando l'immagine occorre (purtroppo) riscalare a mano anche le coordinate. */ | /* "Logo" ad esagoni con mappa dei link. Le coordinate sono scalate sull'immagine ridimensionata, riscalando l'immagine occorre (purtroppo) riscalare a mano anche le coordinate. */ | ||
| - | * [[en:aree:calcolo:start|Area Calcolo Scientifico @ 166,3,208,3,230,40,208,77,166,78,144,41]] | + | * [[en:aree:calcolo:start|Area Calcolo Scientifico @ 124,100,175,100,201,144,176,189,125,189,99,145]] |
| - | * [[en:aree:ngs:start|Area Sequenziamento @ 308,84,351,84,372,121,351,158,308,158,287,122]] | + | * [[en:aree:ngs:start|Area Sequenziamento @ 209,53,260,52,286,97,261,141,209,141,185,97]] |
| - | * [[en:aree:fabiocell:start|Area FaBioCell @ 237,42,279,42,301,79,280,117,237,118,215,80]] | + | * [[en:aree:citometria:start|Area Citometria @ 210,149,261,149,286,193,261,238,210,238,185,193]] |
| - | * [[en:aree:citometria:start|Area Citometria @ 237,126,280,125,301,162,280,199,237,200,216,162]] | + | * [[en:aree:epr:start|Area EPR @ 125,197,176,197,201,241,176,286,125,285,100,242]] |
| - | * [[en:aree:epr:start|Area EPR @ 165,166,208,166,230,203,208,240,166,239,144,203]] | + | * [[en:aree:nmr:start|Area NMR @ 39,149,89,149,115,193,90,237,39,237,14,193]] |
| - | * [[en:aree:nmr:start|Area NMR @ 93,125,136,125,157,162,136,199,93,199,72,163]] | + | * [[en:aree:microscopia:start|Area Microscopia @ 98,48,124,3,174,3,200,47,174,92,124,91]] |
| - | * [[en:aree:microscopia:start|Area Microscopia @ 23,84,66,84,88,120,66,158,23,159,1,121]] | + | * [[en:aree:proteomica:start|Area Proteomica @ 39,51,90,51,116,94,91,139,39,139,14,95]] |
| - | * [[en:aree:proteomica:start|Area Proteomica @ 93,42,136,42,158,79,136,117,94,117,72,80]] | + | |
| - | * [[en:aree:start|Aree @ 166,84,211,84,234,123,211,160,166,160,145,122]] | + | |
| {{<map}} | {{<map}} | ||
| Line 239: | Line 237: | ||
| <wrap bigger>**GENEVAX Project**</wrap> | <wrap bigger>**GENEVAX Project**</wrap> | ||
| - | {{ :aree:fabiocell:genevax-loghi.png?350 |}} | + | {{ :recycler:20250823-fabiocell:genevax-loghi.png?350 |}} |
| - | In the context of the **POR FESR, Key Enabling Technologies (KETs)** calls, the FaBioCell cell factory has recently received a loan from **[[http://www.lazioinnova.it|Lazio Innova]]** for the **[[http://www.evvivax.com/index.php/13-research/67-from-genes-to-translational-vaccines-genevax|GENEVAX]]** project, developed in collaboration with **[[http://www.evvivax.com|EVVIVAX]]**, a biotech dedicated to immunotherapy in the veterinary field [[en:aree:fabiocell:ricerca#genevax_project|[read more...]]] | + | In the context of the **POR FESR, Key Enabling Technologies (KETs)** calls, the FaBioCell cell factory has recently received a loan from **[[http://www.lazioinnova.it|Lazio Innova]]** for the **[[http://www.evvivax.com/index.php/13-research/67-from-genes-to-translational-vaccines-genevax|GENEVAX]]** project, developed in collaboration with **[[http://www.evvivax.com|EVVIVAX]]**, a biotech dedicated to immunotherapy in the veterinary field [[en:recycler:20250823-fabiocell:ricerca#genevax_project|[read more...]]] |
| Line 594: | Line 592: | ||
| <wrap bigger>**GENEVAX Project**</wrap> | <wrap bigger>**GENEVAX Project**</wrap> | ||
| - | {{ :aree:fabiocell:genevax-loghi.png?350 |}} | + | {{ :recycler:20250823-fabiocell:genevax-loghi.png?350 |}} |
| - | In the context of the **POR FESR, Key Enabling Technologies (KETs)** calls, the FaBioCell cell factory has recently received a loan from **[[http://www.lazioinnova.it|Lazio Innova]]** for the **[[http://www.evvivax.com/index.php/13-research/67-from-genes-to-translational-vaccines-genevax|GENEVAX]]** project, developed in collaboration with **[[http://www.evvivax.com|EVVIVAX]]**, a biotech dedicated to immunotherapy in the veterinary field [[en:aree:fabiocell:ricerca#genevax_project|[read more...]]] | + | In the context of the **POR FESR, Key Enabling Technologies (KETs)** calls, the FaBioCell cell factory has recently received a loan from **[[http://www.lazioinnova.it|Lazio Innova]]** for the **[[http://www.evvivax.com/index.php/13-research/67-from-genes-to-translational-vaccines-genevax|GENEVAX]]** project, developed in collaboration with **[[http://www.evvivax.com|EVVIVAX]]**, a biotech dedicated to immunotherapy in the veterinary field [[en:recycler:20250823-fabiocell:ricerca#genevax_project|[read more...]]] |
